Trastuzumab duocarmazine

MedChem Express

Trastuzumab duocarmazine

10

Research Use Only

99.87

Trastuzumab duocarmazine ((vic)-Trastuzumab duocarmazine) is a HER2-targeting ADC that is recognized and cleaved by histone B in tumor cells and selectively targets tumor cells. Trastuzumab duocarmazine has anti-tumor activity and can be used in cancer research related to uterine and ovarian sarcomas [1] .

-80°C

12352203